Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer

E-ISSN： 1873-5592|11|1|85-94

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.1, 2010-01, pp. : 85-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pemetrexed for the treatment of non-small cell lung cancer

By Genova Carlo

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. : 1545-1558

Informa Healthcare

Access to resources Recommend Favorite

An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer

By Scagliotti Giorgio

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2855-2866

Informa Healthcare

Access to resources Recommend Favorite

Pemetrexed in advanced non-small cell lung cancer

By Gridelli Cesare Maione Paolo Rossi Antonio Bareschino Maria Anna Schettino Clorinda Sacco Paola Claudia Zeppa Rosario

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite

Erlotinib in non-small cell lung cancer: a review

By Blackhall Fiona H Rehman Shazza Thatcher Nicholas

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 6, 2005-06 ,pp. : 995-1002

Informa Healthcare

Access to resources Recommend Favorite

Pemetrexed: Potential Role in the Adjuvant Chemotherapy of Non-Small Cell Lung Cancer

Current Drug Targets, Vol. 11, Iss. 1, 2010-01 ,pp. : 78-84

Bentham Science Publishers

Access to resources Recommend Favorite